This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2014 Oct;312(16):1629-30.

doi: 10.1001/jama.2014.13235.

Indication-specific pricing for cancer drugs

Affiliations

PMID: 25279433
DOI: 10.1001/jama.2014.13235

Indication-specific pricing for cancer drugs

Peter B Bach. JAMA. 2014 Oct.

. 2014 Oct;312(16):1629-30.

doi: 10.1001/jama.2014.13235.

Author

Affiliation

¹ Health Outcomes Research Group, Memorial Sloan-Kettering Cancer Center, New York, New York.

PMID: 25279433
DOI: 10.1001/jama.2014.13235

No abstract available

PubMed Disclaimer

Comment in

Alternative pricing strategies for cancer drugs.
Messori A, De Rosa M, Pani L. Messori A, et al. JAMA. 2015 Feb 24;313(8):857. doi: 10.1001/jama.2014.17814. JAMA. 2015. PMID: 25710668 No abstract available.
Alternative pricing strategies for cancer drugs--reply.
Bach PB. Bach PB. JAMA. 2015 Feb 24;313(8):858. doi: 10.1001/jama.2014.17817. JAMA. 2015. PMID: 25710670 No abstract available.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations